ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0979

IL-23 upregulates IFN-γ secretion in Th17.1, but not in Th17 or classical Th1 cells

Bennie van Heeswijk1, Wida Razawy2, Anne-Marie Mus-Otten3, Patrick Asmawidjaja2, Pieter Leenen2 and Erik Lubberts4, 1Erasmus MC, University Medical Center Rotterdam, Hoofddorp, Netherlands, 2Erasmus University Medical Center, Rotterdam, the Netherlands, Rotterdam, Netherlands, 3Erasmus medical center, Rotterdam, Netherlands, 4Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands

Meeting: ACR Convergence 2025

Keywords: immunology, Interleukins, T Cell, TH17 Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (0978–1006) T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Interleukin-23 (IL-23) is a key cytokine in the pathogenesis of psoriatic diseases, as demonstrated by the clinical success of IL-23-targeted therapies. Monocytes are a primary source of IL-23, contributing to the inflammatory milieu.IL-23 is known to drive the pathogenicity of T-helper (Th) cells with a CCR6⁺ phenotype; however, its specific effects on distinct memory T cell subsets remain poorly defined. The CCR6⁺ Th population is heterogeneous, comprising Th17 cells, which predominantly produce IL-17A, and Th17.1 cells, which mainly secrete interferon-gamma (IFN-γ). We aim to characterize the interactions between IL-23 and the different CCR6+ Ths, which is essential for advancing our understanding of psoriatic disease mechanisms and improving therapeutic strategies.

Methods: Human CCR6+, CCR6-, Th17, Th17.1 and classical Th1 cells were sorted from peripheral blood mononuclear cells (PBMCs). Transcription of IL-23R was determined with RT-PCR. CCR6+, CCR6-, Th17, Th17.1 and Th1 cells were stimulated with αCD3/αCD28, in the presence or absence of IL-23 for 72h before measuring cytokine secretion with ELISA. CD14+ monocytes were isolated using MACS and cocultured with Th cell populations before measuring IFN-γ secretion with ELISA.

Results: Ex vivo analysis revealed that CCR6⁺ T-helper cells expressed significantly higher levels of IL-23R mRNA compared to CCR6⁻ counterparts. Upon stimulation with IL-23, CCR6⁺ Th cells secreted significantly more interferon-gamma (IFN-γ), but not interleukin-17A (IL-17A). To account for the heterogeneity within the CCR6⁺ population, memory Th17, Th17.1, and classical CCR6⁻ Th1 cells were further sorted and analyzed. Both Th17 and Th17.1 cells exhibited higher IL-23R expression than Th1 cells. Following IL-23 stimulation, Th17.1 cells produced significantly more IFN-γ, whereas Th17 and Th1 cells did not. IFN-γ was found to induce IL-23 production in CD14⁺ monocytes. In co-culture experiments with monocytes, Th17.1 cells secreted significantly more IFN-γ than classical Th1 cells.

Conclusion: T-helper cell subsets exhibit distinct responses to IL-23, particularly in their ability to produce IFN-γ. Our data show that IL-23 selectively induces IFN-γ secretion in Th17.1 cells, but not in Th17 or classical Th1 cells. Additionally, IFN-γ promotes IL-23 production by monocytes, suggesting a proinflammatory feedback loop that may amplify Th17.1-mediated inflammation. When co-cultured with monocytes, Th17.1 cells produced more IFN-γ than Th1 cells, further underscoring their heightened pro-inflammatory potential. These findings highlight a unique IL-23–IFN-γ axis in Th17.1 cells that may contribute significantly to local tissue inflammation in psoriatic diseases.

Supporting image 1Schematic overview of the IL-23/IFNg proinflammatory feedback loop.


Disclosures: B. van Heeswijk: None; W. Razawy: None; A. Mus-Otten: None; P. Asmawidjaja: None; P. Leenen: None; E. Lubberts: None.

To cite this abstract in AMA style:

van Heeswijk B, Razawy W, Mus-Otten A, Asmawidjaja P, Leenen P, Lubberts E. IL-23 upregulates IFN-γ secretion in Th17.1, but not in Th17 or classical Th1 cells [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/il-23-upregulates-ifn-%ce%b3-secretion-in-th17-1-but-not-in-th17-or-classical-th1-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-23-upregulates-ifn-%ce%b3-secretion-in-th17-1-but-not-in-th17-or-classical-th1-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology